Review Article
The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
Table 2
The efficacy of combination of TACE with RFA or MWA vs. monotherapy.
| | References | Methods | Patients | Age (years) | Size (cm) | Response rates (%) | Overall survival (OS) rates (%) | OS value | | 0.5 yr | 1 yr | 1.5 yr | 2 yr |
| | Liu et al. [44] | TACE | 43 | 44-78 | 5-14 | 67.4 | — | — | — | — | 0.081 | | TACE-RFA | 45 | 45-75 | 4-15 | 91.1 | — | — | — | — |
| | Peng et al. [46] | RFA | 95 | | | 96.8 | — | 66.6 | — | — | 0.002 | | TACE-RFA | 94 | | | 96.8 | — | 92.6 | — | — |
| | Liu et al. [50] | TACE | 18 | | | 38.9 | 50 | 11.1 | 0 | 0 | 0.003 | | TACE-MWA | 16 | | | 87.5 | 75 | 33.3 | 18.7 | 6.25 |
| | Chen et al. [51] | TACE | 96 | | | 46.3 | 96.9 | 87.2 | 81.1 | 77 | 0.317 | | TACE-MWA | 48 | | | 92.1 | 100 | 91.7 | 88.5 | 88.5 |
| | Zheng et al. [52] | TACE | 166 | | | 55.4 | — | 59 | — | 40.4 | <0.001 | | TACE-MWA | 92 | | | 81.5 | — | 85.9 | — | 59.8 |
|
|
